Literature DB >> 20356606

The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke.

Seung-Hun Oh1, Nam-Keun Kim, Sang-Heum Kim, Jin-Kyeoung Kim, Hyun-Sook Kim, Won-Chan Kim, Ok-Joon Kim.   

Abstract

BACKGROUND: To evaluate the prevalence and to identify the risk factors of silent brain infarction (SBI) in patients with ischemic stroke.
METHODS: A total of 395 consecutive patients with first-ever ischemic stroke that underwent brain MRI were enrolled in this study. The prevalences of vascular risk factors in a SBI-positive (n=132) and in a SBI-negative group (n=263) were compared. The prevalences and characteristics of SBI were further evaluated with respect to stroke subtype and periventricular white-matter hyperintensity (PWMH) lesion.
RESULTS: The frequency of SBI among the 395 study subjects was 33.4%, and 10.1% of the study subjects had multiple-SBI lesions. The most common lesion site was basal ganglia (47%). Multiple logistic regression analysis showed that hypertension (OR: 1.94, 95% CI: 1.22-3.07, P=0.005) and the presence of an advanced PWMH lesion (OR: 1.77, 95% CI: 1.06-2.96, P=0.030) were significantly associated with SBI. Furthermore, an advanced PWMH lesion (OR: 2.88, 95% CI: 1.19-6.95, P=0.010) was more associated with multiple-SBI lesions than with a single-SBI lesion. The frequency of SBI was higher among those with the small-vessel disease type (45.5%) than in those with the large-artery disease (32.5%) or cardioembolic stroke type (25.6%) (P=0.04).
CONCLUSIONS: The prevalence of SBI in patients with ischemic stroke was found to be high, and hypertension was found to be the most important risk factor of SBI. Small-vessel disease and a diffuse white-matter lesion were found to be closely associated with SBI, and especially with multiple-SBI lesions. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20356606     DOI: 10.1016/j.jns.2010.02.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.

Authors:  Ralph Weber; Christian Weimar; Isabel Wanke; Claudia Möller-Hartmann; Elke R Gizewski; Jon Blatchford; Karin Hermansson; Andrew M Demchuk; Michael Forsting; Ralph L Sacco; Jeffrey L Saver; Steven Warach; Hans Christoph Diener; Anke Diehl
Journal:  Stroke       Date:  2012-01-19       Impact factor: 7.914

2.  Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults.

Authors:  Rohith N Thota; Pratishtha Chatterjee; Steve Pedrini; Eugene Hone; Jessica J A Ferguson; Manohar L Garg; Ralph N Martins
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

Review 3.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

4.  Symptomatic and silent cerebral infarction following surgical clipping of unruptured intracranial aneurysms: incidence, risk factors, and clinical outcome.

Authors:  Maogui Li; Jun Wu; Xin Chen; Pengjun Jiang; Fan Yang; Yonggang Ma; Zhengsong Li; Yong Cao; Shuo Wang
Journal:  Neurosurg Rev       Date:  2017-10-05       Impact factor: 3.042

5.  Clinical symptoms and risk factors in cerebral microangiopathy patients.

Authors:  Sandra Okroglic; Catherine N Widmann; Horst Urbach; Philip Scheltens; Michael T Heneka
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

6.  Silent brain infarction in the presence of systemic vascular disease.

Authors:  Julia Slark; Paul Bentley; Pankaj Sharma
Journal:  JRSM Cardiovasc Dis       Date:  2012-04-05

7.  Phenotypes of Chronic Covert Brain Infarction in Patients With First-Ever Ischemic Stroke: A Cohort Study.

Authors:  Jan Vynckier; Johannes Kaesmacher; Urs Fischer; Thomas Raphael Meinel; Joanna Marguerite Wardlaw; Laurent Roten; Morin Beyeler; Nebiyat Filate Belachew; Lorenz Grunder; David Julian Seiffge; Simon Jung; Jan Gralla; Tomas Dobrocky; Mirjam Rachel Heldner; Ulrike Prange; Martina Béatrice Goeldlin; Marcel Arnold
Journal:  Stroke       Date:  2021-09-16       Impact factor: 7.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.